EUVIMEDEUVIMED entdecken
Crossref

Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia

Bartosz Puła

Acta Haematologica Polonica · 29.10.2026 · 57 (5) · 351-352

DOI: 10.5603/ahp.115371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica Polonica, online erschienen am 29.10.2026. Verfasst von Bartosz Puła.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Puła, B. (2026). Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia. Acta Haematologica Polonica, 57(5), 351-352. https://doi.org/10.5603/ahp.115371

Vancouver

Puła B. Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia. Acta Haematologica Polonica. 2026;57(5):351-352. doi:10.5603/ahp.115371

BibTeX
@article{Pua2026,
  author = {Puła, Bartosz},
  title = {Pirtobrutinib and the next phase of precision therapy in chronic lymphocytic leukemia},
  journal = {Acta Haematologica Polonica},
  year = {2026},
  volume = {57},
  number = {5},
  pages = {351--352},
  doi = {10.5603/ahp.115371}
}
Kostenlos starten →